# Reflux Esophagitis Phase III Study (Maintenance Treatment)

> **NCT00634114** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 540 (actual)

## Conditions studied

- Reflux Esophagitis

## Interventions

- **DRUG:** Esomeprazole
- **DRUG:** Esomeprazole
- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT00634114
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** —
- **Final completion:** 2009-05
- **Target enrollment:** 540 (ACTUAL)
- **Last updated:** 2010-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00634114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00634114, "Reflux Esophagitis Phase III Study (Maintenance Treatment)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00634114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*